In breast cancer cells, UBE2Q1 overexpression downregulates p53 and increases cell resistance to apoptosis, indicating that UBE2Q1 offers a protective role in tumor cells through ubiquitination and proteasome degradation of p53 [34]. Here, UBE2Q1 is linked to breast carcinoma.